drugset / Trial / NCT05983328
Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Fasting Period: At least 10 hours prior to dosing until 4 hours post-dose of each study period. Period: 24 hours post dose in each period. Each subject will complete two study periods. Washout Period: At least one week after dosing of the previous period. Confinement: From at least 10 hours prior to dosing until at least 12 hours post-dose, for a total of at least 22 hours for each study period.
Timeline
- Start
- 2016-05-10
- Primary completion
- 2016-05-26
- Completion
- 2018-02-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HUYPS-1 | Unknown | — | Oral |